mTOR signalling and cellular metabolism are mutual determinants in cancer

Mossmann, Dirk and Park, Sujin and Hall, Michael N.. (2018) mTOR signalling and cellular metabolism are mutual determinants in cancer. Nature Reviews. Cancer, 18 (12). pp. 744-757.

[img] PDF - Accepted Version

Official URL: https://edoc.unibas.ch/66829/

Downloads: Statistics Overview


Oncogenic signalling and metabolic alterations are interrelated in cancer cells. mTOR, which is frequently activated in cancer, controls cell growth and metabolism. mTOR signalling regulates amino acid, glucose, nucleotide, fatty acid and lipid metabolism. Conversely, metabolic inputs, such as amino acids, activate mTOR. In this Review, we discuss how mTOR signalling rewires cancer cell metabolism and delineate how changes in metabolism, in turn, sustain mTOR signalling and tumorigenicity. Several drugs are being developed to perturb cancer cell metabolism. However, their efficacy as stand-alone therapies, similar to mTOR inhibitors, is limited. Here, we discuss how the interdependence of mTOR signalling and metabolism can be exploited for cancer therapy.
Faculties and Departments:05 Faculty of Science > Departement Biozentrum > Growth & Development > Biochemistry (Hall)
UniBasel Contributors:Hall, Michael N.
Item Type:Article, refereed
Article Subtype:Research Article
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
edoc DOI:
Last Modified:01 Feb 2021 10:54
Deposited On:29 Nov 2018 16:48

Repository Staff Only: item control page